PYC THERAPEUTICS ORDINARY (PYC) Short Interest
PYC THERAPEUTICS ORDINARY (ASX:PYC) had 0.36% of shares reported as short positions as of 4 June 2026, representing 3,508,917 shares. PYC THERAPEUTICS ORDINARY operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
- Short interest
- 0.36%
- Reported positions
- 3,508,917
- Industry
- Pharmaceuticals, Biotechnology & Life Sciences
- As of
- 4 June 2026
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
PYC
Pyc Therapeutics
PYC Therapeutics is a clinical-stage biotech company focused on developing RNA therapies to address genetic diseases. Their proprietary RNA delivery platform aims to provide safer and more effective treatments by targeting the underlying causes of these diseases. The company is advancing a pipeline of novel therapies for eye, central nervous system, and kidney diseases.